|
J Biol Chem, Vol. 275, Issue 8, 5466-5471, February 25, 2000
Human Vascular Smooth Muscle Cells Possess Functional CCR5*
Alison D.
Schecterabk,
Tina M.
Calderonc,
Adriane B.
Bermanab,
Carrie M.
McManusc,
John T.
Fallonabd,
Maria
Rossikhinaab,
Weixin
Zhaoe,
George
Christef,
Joan W.
Bermancg, and
Mark B.
Taubmanabhj
From the a Zena and Michael A. Wiener Cardiovascular
Institute and the Departments of b Medicine, h Physiology
and Biophysics, and d Pathology, The Mount Sinai School of
Medicine, New York, New York 10029 and the Departments of
g Microbiology and Immunology, c Pathology,
e Urology, and f Physiology and Biophysics, Albert
Einstein College of Medicine, Bronx, New York 10461
CC chemokine receptors are important modulators
of inflammation. Although CC chemokine receptors have been found
predominantly on leukocytes, recent studies have suggested that
vascular smooth muscle cells respond to CC chemokines. We now report
that human smooth muscle cells express CCR5, a co-receptor for human
immunodeficiency virus. CCR5 mRNA was detectable by RNA blot
hybridization in human aortic and coronary artery smooth muscle cells.
The cDNA generated by reverse transcription-polymerase chain
reaction from aortic smooth muscle cells had 100% identity throughout
the entire coding region with the CCR5 cloned from THP-1 cells. By
immunohistochemistry, CCR5 and the CCR5 ligand, macrophage inflammatory
protein-1 (MIP-1 ), were detected in smooth muscle cells and
macrophages of the atherosclerotic plaque. In smooth muscle cell
culture, MIP-1 induced a significant increase in intracellular
calcium concentrations, which was blocked by an antibody to CCR5. In
addition, MIP-1 caused a calcium-dependent increase in
tissue factor activity. Tissue factor is the initiator of coagulation
and is thought to play a key role in arterial thrombosis. These data
suggest that human arterial smooth muscle cells express functional CCR5
receptors and MIP-1 is an agonist for these cells.
*
This work was supported by National Institutes of Health
Grants HL29019 and HL 54469 and by NIMH, National Institutes of Health, Grant MH52974.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
j
To whom correspondence should be addressed: Box 1269, Mount
Sinai School of Medicine, One Gustave L. Levy Pl., New York, NY 10029. Tel.: 212-241-0047; Fax: 212-860-7032; E-mail:
mark.taubman@mssm.edu.
k
Recipient of National Institutes of Health Mentored Clinical
Scientist Development Award HL03801.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. L.H. Muntinghe, M. Verduijn, M. W. Zuurman, D. C. Grootendorst, J. J. Carrero, A. R. Qureshi, K. Luttropp, L. Nordfors, B. Lindholm, V. Brandenburg, et al.
CCR5 Deletion Protects Against Inflammation-Associated Mortality in Dialysis Patients
J. Am. Soc. Nephrol.,
July 1, 2009;
20(7):
1641 - 1649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pacheco-Rodriguez, F. Kumaki, W. K. Steagall, Y. Zhang, Y. Ikeda, J.-P. Lin, E. M. Billings, and J. Moss
Chemokine-Enhanced Chemotaxis of Lymphangioleiomyomatosis Cells with Mutations in the Tumor Suppressor TSC2 Gene
J. Immunol.,
February 1, 2009;
182(3):
1270 - 1277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Eugenin, S. Morgello, M. E. Klotman, A. Mosoian, P. A. Lento, J. W. Berman, and A. D. Schecter
Human Immunodeficiency Virus (HIV) Infects Human Arterial Smooth Muscle Cells in Vivo and in Vitro: Implications for the Pathogenesis of HIV-Mediated Vascular Disease
Am. J. Pathol.,
April 1, 2008;
172(4):
1100 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Barlic and P. M. Murphy
Chemokine regulation of atherosclerosis
J. Leukoc. Biol.,
August 1, 2007;
82(2):
226 - 236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Mitchell and P. Libby
Vascular Remodeling in Transplant Vasculopathy
Circ. Res.,
April 13, 2007;
100(7):
967 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Braunersreuther, A. Zernecke, C. Arnaud, E. A. Liehn, S. Steffens, E. Shagdarsuren, K. Bidzhekov, F. Burger, G. Pelli, B. Luckow, et al.
Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2007;
27(2):
373 - 379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Holven, J. K. Damas, A. Yndestad, T. Waehre, T. Ueland, B. Halvorsen, L. Heggelund, W. J. Sandberg, A. G. Semb, S. S. Froland, et al.
Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2006;
26(1):
200 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J.A. van Wanrooij, H. Happe, A. D. Hauer, P. de Vos, T. Imanishi, H. Fujiwara, T. J.C. van Berkel, and J. Kuiper
HIV Entry Inhibitor TAK-779 Attenuates Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2005;
25(12):
2642 - 2647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. van Deventer, W. O'Connor Jr., W. J. Brickey, R. M. Aris, J. P.Y. Ting, and J. S. Serody
C-C Chemokine Receptor 5 on Stromal Cells Promotes Pulmonary Metastasis
Cancer Res.,
April 15, 2005;
65(8):
3374 - 3379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Furnkranz, A. Schober, V. N. Bochkov, P. Bashtrykov, G. Kronke, A. Kadl, B. R. Binder, C. Weber, and N. Leitinger
Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2005;
25(3):
633 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. F. Charo and M. B. Taubman
Chemokines in the Pathogenesis of Vascular Disease
Circ. Res.,
October 29, 2004;
95(9):
858 - 866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. Kodali, W. J.H. Kim, I. I. Galaria, C. Miller, A. D. Schecter, S. A. Lira, and M. B. Taubman
CCL11 (Eotaxin) Induces CCR3-Dependent Smooth Muscle Cell Migration
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2004;
24(7):
1211 - 1216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Schecter, A. B. Berman, L. Yi, H. Ma, C. M. Daly, K. Soejima, B. J. Rollins, I. F. Charo, and M. B. Taubman
MCP-1-dependent signaling in CCR2-/- aortic smooth muscle cells
J. Leukoc. Biol.,
June 1, 2004;
75(6):
1079 - 1085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pyo, K. K. Jensen, M. T. Wiekowski, D. Manfra, A. Alcami, M. B. Taubman, and S. A. Lira
Inhibition of Intimal Hyperplasia in Transgenic Mice Conditionally Expressing the Chemokine-Binding Protein M3
Am. J. Pathol.,
June 1, 2004;
164(6):
2289 - 2297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Oostendorp, M. N. Hylkema, M. Luinge, M. Geerlings, H. Meurs, W. Timens, J. Zaagsma, D. S. Postma, H. W. Boddeke, and K. Biber
Localization and Enhanced mRNA Expression of the Orphan Chemokine Receptor L-CCR in the Lung in a Murine Model of Ovalbumin-induced Airway Inflammation
J. Histochem. Cytochem.,
March 1, 2004;
52(3):
401 - 410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Haque, J. T. Fallon, J. J. Pan, M. B. Taubman, and P. C. Harpel
Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion
Blood,
February 15, 2004;
103(4):
1296 - 1304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Veillard, B. Kwak, G. Pelli, F. Mulhaupt, R. W. James, A. E.I. Proudfoot, and F. Mach
Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice
Circ. Res.,
February 6, 2004;
94(2):
253 - 261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Tarzami, W. Miao, K. Mani, L. Lopez, S. M. Factor, J. W. Berman, and R. N. Kitsis
Opposing Effects Mediated by the Chemokine Receptor CXCR2 on Myocardial Ischemia-Reperfusion Injury: Recruitment of Potentially Damaging Neutrophils and Direct Myocardial Protection
Circulation,
November 11, 2003;
108(19):
2387 - 2392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Holven, A. M. Myhre, P. Aukrust, T. A. Hagve, L. Ose, and M. S. Nenseter
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo: Dependency of xanthomas/xanthelasms, smoking and gender
Eur. Heart J.,
October 1, 2003;
24(19):
1756 - 1762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Waehre, J. K. Damas, L. Gullestad, A. M. Holm, T. R. Pedersen, K. E. Arnesen, H. Torsvik, S. S. Froland, A. G. Semb, and P.a. Aukrust
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
J. Am. Coll. Cardiol.,
May 7, 2003;
41(9):
1460 - 1467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nakajima, Y. Tanaka, T. Nomiyama, T. Ogihara, F. Ikeda, R. Kanno, N. Iwashita, K. Sakai, H. Watada, T. Onuma, et al.
RANTES Promoter Genotype Is Associated With Diabetic Nephropathy in Type 2 Diabetic Subjects
Diabetes Care,
March 1, 2003;
26(3):
892 - 898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Ambati, A. Anand, A. M. Joussen, W. A. Kuziel, A. P. Adamis, and J. Ambati
Sustained Inhibition of Corneal Neovascularization by Genetic Ablation of CCR5
Invest. Ophthalmol. Vis. Sci.,
February 1, 2003;
44(2):
590 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Takayama, G. Garcia-Cardena, G. K. Sukhova, J. Comander, M. A. Gimbrone Jr., and P. Libby
Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor
J. Biol. Chem.,
November 8, 2002;
277(46):
44147 - 44154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nakajima, Y. Tanaka, T. Nomiyama, T. Ogihara, L. Piao, K. Sakai, T. Onuma, and R. Kawamori
Chemokine Receptor Genotype Is Associated With Diabetic Nephropathy in Japanese With Type 2 Diabetes
Diabetes,
January 1, 2002;
51(1):
238 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Schonbeck and P. Libby
CD40 Signaling and Plaque Instability
Circ. Res.,
December 7, 2001;
89(12):
1092 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vakili, L. Standker, M. Detheux, G. Vassart, W.-G. Forssmann, and M. Parmentier
Urokinase Plasminogen Activator and Plasmin Efficiently Convert Hemofiltrate CC Chemokine 1 into Its Active [9-74] Processed Variant
J. Immunol.,
September 15, 2001;
167(6):
3406 - 3413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Schecter, A. B. Berman, L. Yi, A. Mosoian, C. M. McManus, J. W. Berman, M. E. Klotman, and M. B. Taubman
HIV envelope gp120 activates human arterial smooth muscle cells
PNAS,
August 10, 2001;
(2001)
181328798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Detheux, L. Standker, J. Vakili, J. Munch, U. Forssmann, K. Adermann, S. Pohlmann, G. Vassart, F. Kirchhoff, M. Parmentier, et al.
Natural Proteolytic Processing of Hemofiltrate CC Chemokine 1 Generates a Potent CC Chemokine Receptor (CCR)1 and CCR5 Agonist with Anti-HIV Properties
J. Exp. Med.,
November 20, 2000;
192(10):
1501 - 1508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bonacchi, P. Romagnani, R. G. Romanelli, E. Efsen, F. Annunziato, L. Lasagni, M. Francalanci, M. Serio, G. Laffi, M. Pinzani, et al.
Signal Transduction by the Chemokine Receptor CXCR3. ACTIVATION OF Ras/ERK, Src, AND PHOSPHATIDYLINOSITOL 3-KINASE/Akt CONTROLS CELL MIGRATION AND PROLIFERATION IN HUMAN VASCULAR PERICYTES
J. Biol. Chem.,
March 23, 2001;
276(13):
9945 - 9954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Schecter, A. B. Berman, L. Yi, A. Mosoian, C. M. McManus, J. W. Berman, M. E. Klotman, and M. B. Taubman
HIV envelope gp120 activates human arterial smooth muscle cells
PNAS,
August 28, 2001;
98(18):
10142 - 10147.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|